Literature DB >> 170109

Human prolyl hydroxylase. Purification, partial characterization and preparation of antiserum to the enzyme.

E R Kuutti, L Tuderman, K I Kivirikko.   

Abstract

Prolyl hydroxylase was purified from human foetal skin and from a mixture of human foetal tissues by the affinity chromatography procedure using poly(L-proline). The enzyme from both sources was pure, when examined by polyacrylamide gel electrophoresis, as a native protein or in the presence of sodium dodecylsulphate, and enzyme activity recovery varied from 38% to 70% with seven enzyme preparations. The enzyme synthesized from 61.0 mumol to 82.7 mumol hydroxyproline mg protein-1 h-1 degrees C with a saturating concentration of (Pro-Pro-Gly)5 as substrate. The molecular weight of the enzyme was identical with that of the chick prolyl hydroxylase when studied by gel filtration, and the molecular weights of the subunits of the enzyme were about 61000 and 64000 as determined by sodium dodecylsulphate-polyacrylamide gel electrophoresis. The amino acid composition of the human enzyme was very similar to that of the chick prolyl hydroxylase. Antisera to human and chick prolyl hydroxylases were prepared in rabbits. A single precipitin line was seen between the antiserum to human prolyl hydroxylase and the human enzyme in double immunodiffusion, and no cross-reactivity was detected between the human chick enzymes by this technique. However, a distinct cross-reactivity was observed between the human and chick enzymes in inhibition experiments.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170109     DOI: 10.1111/j.1432-1033.1975.tb02289.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Turnover of prolyl hydroxylase tetramers and the monomer-size protein in chick-embryo cartilaginous bone and lung in vivo.

Authors:  K Majamaa; E R Kuutti-Savolainen; L Tuderman; K I Kivirikko
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

2.  Isolation and characterization of prolyl hydroxylase from Chlamydomonas reinhardii.

Authors:  P Blankenstein; W C Lang; D G Robinson
Journal:  Planta       Date:  1986-10       Impact factor: 4.116

3.  Homology between a prolyl hydroxylase subunit and a tissue protein that crossreacts immunologically with the enzyme.

Authors:  S Chen-Kiang; G J Cardinale; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Immunological characterization of lysyl hydroxylase, an enzyme of collagen synthesis.

Authors:  T M Turpeenniemi-Hujanen
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

5.  Regulation of collagen post-translational modification in transformed human and chick-embryo cells.

Authors:  R Myllylä; K Alitalo; A Vaheri; K I Kivirikko
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

6.  The assembly of tetrameric prolyl hydroxylase in tendon fibroblasts from newly synthesized alpha-subunits and from preformed cross-reacting protein.

Authors:  R A Berg; W W Kao; N L Kedersha
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

7.  Serum immunoreactive prolyl hydroxylase in inflammatory rheumatic diseases.

Authors:  E R Kuutti-Savolainen; K I Kivirikko; O Laitinen
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

8.  Isolation of lysyl hydroxylase, an enzyme of collagen synthesis, from chick embryos as a homogeneous protein.

Authors:  T M Turpeenniemi-Hujanen; U Puistola; K I Kivirikko
Journal:  Biochem J       Date:  1980-08-01       Impact factor: 3.857

9.  Morphological identification of and collagen synthesis by periacinar fibroblastoid cells cultured from isolated rat pancreatic acini.

Authors:  Y Kato; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

10.  The effects of long-term local PUVA treatment on collagen metabolism in human skin.

Authors:  N Väätäinen; A Oikarinen; E R Kuutti-Savolainen
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.